Stock listing
RMTG Stock Price, News, Filings & Events — Regenerative Medical Technology Group Inc.
Selected listing: RMTG · OTC · USD · US
This page tracks Regenerative Medical Technology Group Inc.'s RMTG:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RMTG:OTC. RMTG:OTC is the stock-level entry point for investors researching Regenerative Medical Technology Group Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regenerative Medical Technology Group Inc. (RMTG) is a public company based in the United States, focused on advancements in regenerative medicine. With a market capitalization of approximately $1.25 million, the company is positioned within the growing healthcare sector. RMTG aims to develop innovative solutions to improve patient outcomes through its technology.

- Ticker
- RMTG:OTC
- Asset type
- Stock
- Market cap
- $1.2M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- OTC
- Currency
- USD
Regenerative Medical Technology Group Inc. RMTG:OTC stock context
This page tracks Regenerative Medical Technology Group Inc.'s RMTG:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RMTG:OTC. RMTG:OTC is the stock-level entry point for investors researching Regenerative Medical Technology Group Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regenerative Medical Technology Group Inc. (RMTG) is a public company based in the United States, focused on advancements in regenerative medicine. With a market capitalization of approximately $1.25 million, the company is positioned within the growing healthcare sector. RMTG aims to develop innovative solutions to improve patient outcomes through its technology.
Latest news from Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engin...
September 14, 2026
Cellgenic Establishes Local Commercial Presence in Brazil
September 3, 2026
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 1, 2026
RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
August 27, 2026
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
August 26, 2026
Research Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group Inc. investor report
Review AI stock analysis and investor report context for RMTG:OTC.
Regenerative Medical Technology Group Inc. company profile
View the public company page for Regenerative Medical Technology Group Inc. on 6ix.
Regenerative Medical Technology Group Inc. news
Read company news and market updates connected to Regenerative Medical Technology Group Inc..
Regenerative Medical Technology Group Inc. investor events
Find investor webinars, events, and replay context for Regenerative Medical Technology Group Inc..